A misinformation dispute in Japan over Arcturus Therapeutics' COVID-19 vaccine Kostaive (ARCT-154) saw an unprecedented twist in December, when local distributor Meiji Seika Pharma decided to pursue a lawsuit and internal investigation over an Amazon bestseller book.
Meiji Seika Pharma Files Japan Lawsuit Over Kostaive Misinformation
Mysterious Twist In Vaccine Saga
The Japanese pharma firm has sued a politician claiming defamatory actions on social media around its novel COVID-19 vaccine.
